CA-NEXON-AMERICA
12.5.2020 00:41:09 CEST | Business Wire | Press release
Prepare for a thrilling ride as free-to-play mobile kart racer, KartRider Rush+ , launches on iOS and Android devices on May 12. Buckle up to experience a robust set of tracks, innovative and diverse game modes and countless kart customization options that redefine the world of kart racing games.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200511005971/en/
The latest iteration of the insanely popular KartRider franchise, KartRider Rush+ features over 50 race tracks and 20 karts at launch delivering unmatched kart and character customization options, ranging from decals, plates, skins and more.
KartRider Rush + is built for bursts of gameplay on the go or longer durations played with fellow racers offering something for everyone with several modes including:
- Story Mode: Story Mode allows players to fully immerse themselves in the game, learning about character backstories and showcasing various game modes.
- Speed Race Mode: This mode challenges racers to compete against each other and use their drifting skills to earn EXP that can unlock more challenging tracks.
- Arcade Mode: Whether playing solo or in teams, players can enjoy additional gameplay options within Arcade Mode, such as Item Race, Infini-Boost and Lucci Runner.
- Ranked Mode: From Bronze to Living Legend, players can rank up tiers and earn rewards such as K-Coins to purchase a variety of items in the Shop.
- Time Trial: This mode is all about beating the clock to become the fastest racer.
For players looking to achieve ultimate racing prowess, KartRider Rush+ introduces a Mentorship System, which allows racers to team up with mentors to improve their skills or sign up as mentors to guide other players. All players participating in this system will receive mentorship perks and rewards. The Club System also makes it easy for racers to join forces and work together to complete challenges, daily activities and earn rewards.
Additionally, all players will be able to claim the pre-registration milestone rewards until May 25th, 2020. Pre-registration rewards include Skelemech Kart, Slugger Dao Character, Angel Wing Headset, Star Driftmoji and Love Candy Balloon added as a bonus item after reaching 5 million pre-registrations ahead of launch.
To celebrate the launch, KartRider Rush+ has partnered with iconic peripheral manufacturer, HyperX. As part of the partnership, KartRider Rush+ will host giveaways of HyperX gaming peripherals including the HyperX Cloud MIX™ headset and the HyperX ChargePlay Clutch™ designed for longer, more comfortable gaming sessions.
KartRider Rush+ will be available globally in multiple languages including English, Korean, Thai, and Traditional Chinese. Visit https://kartrush.nexon.com for the latest updates and information.
Social Media: Twitch / Facebook / Twitter / Instagram / YouTube
Press Assets:
About KartRider Rush+ https://kartrush.nexon.com
Based on the popular online gaming phenomenon, KartRider , KartRider Rush+ is a free-to-play kart racing mobile game delivering all the racing action of its namesake on iOS and Android devices. With gorgeous 3D graphics, KartRider Rush+ offers players robust tracks, karts and game modes, just like its online counterpart accommodating every level, from racing novice to drifting champion.
About Nexon America Inc. http://www.nexon.net/corporate/about-nexon/
Founded in 2005, Nexon America Inc. delivers outstanding free-to-play online game expertise and live game support, taking the strengths of NEXON Co., Ltd. (“Nexon”) and applying them for uniquely western audiences. Nexon America has consistently sustained iconic franchises such as MapleStory and Mabinogi for more than a decade, which have gone on to break records and captivate players. With new projects on the horizon, Nexon America maintains the pioneering and innovative spirit of its parent company, employing its player-first approach, while designing the best possible gameplay experiences for the western market.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200511005971/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom